Urtė Fultinavičiūtė

Urtė Fultinavičiūtė is a healthcare reporter for Clinical Trials Arena. Urtė's coverage focuses on clinical data management and clinical strategy.

Just announced: Covid-19 continues to dominate the infectious disease clinical trial landscape

We review recently announced late-stage clinical development plans in the infectious disease arena.

All Articles

While many CROs and sponsors already use eTMF, there are still ways to make the most of the technology.

Digital simulation could help break down healthcare barriers, but experts caution the clinical trials sector to go slow.

Early phase cancer drug trials need specialised sites and staff, especially since these studies target specific patients.

With a number of Covid-19 clinical trials in Europe now considered as research waste, sponsors should prepare for more…

Luxa Bio offers a sneak peek of its Phase IIb dry AMD trial plans targeted for H2 2023 or…

High expectations may add to execution challenges in running psychedelic studies.

A poorly negotiated budget can cause friction between sponsors and clinical trial sites, which can lead to fractured working…

Clinical Trials Arena spoke to experts who point to how additional study design parameters can measure and alleviate fertility…